PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16938493-10	2007	Icv-injection of GLP-1 (3 nmol)-induced acceleration of colonic transit was attenuated by vagotomy, atropine and hexamethonium, but not by guanethidine.	Atropine	100-108	glucagon	Rattus norvegicus	17-22	
33469859-10	2021	(4) Pretreatment of atropine and the M3 receptor antagonist 4-DAMP blocked the effects of IES on GLP-1, GIP, and blood glucose.	Atropine	20-28	glucagon	Rattus norvegicus	97-102	
12021207-4	2002	Atropine (a nonspecific muscarinic receptor antagonist) completely inhibited fat-induced GLP-1 secretion in vivo (P < 0.01).	Atropine	0-8	glucagon	Rattus norvegicus	89-94	
15721488-5	2005	Centrally injected atropine sulphate, a muscarinic receptor antagonist (5 microg/10 microl), prevented the gastroprotective effect of GLP-1, while mecamylamine, a nicotinic receptor antagonist (25 microg/10 microl), was ineffective.	Atropine	19-36	glucagon	Rattus norvegicus	134-139	
8804063-6	1996	The stimulation of GLP-1 secretion by methacholine was abolished by addition of atropine and partly reduced by galanin.	Atropine	80-88	glucagon	Rattus norvegicus	19-24	
7490533-5	1995	Arterial infusion of cholinergic agonists strongly enhanced GLP-1 secretion which was counteracted by the addition of atropine.	Atropine	118-126	glucagon	Rattus norvegicus	60-65